On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice

Neuropharmacology

Volumn 62, Issue 1, 2012, Pages 322-331

  Wieronska J M ^a   Stachowicz, K ^a   Branski P ^a   Palucha Poniewiera A ^a   Pilc, A ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Anxiety; GABA; Group II mGlu receptors; LY379268; LY487379; Serotonin

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; ANXIOLYTIC AGENT; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; FLUMAZENIL; LY 487379; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; RITANSERIN; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN 2C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; CORE TEMPERATURE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EXPERIMENTAL TEST; GABAERGIC SYSTEM; HYPERTHERMIA; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEROTONINERGIC NERVE CELL; STRESS; STRESS INDUCED HYPERTHERMIA; TRANQUILIZING ACTIVITY;

AMINO ACIDS; ANALYSIS OF VARIANCE; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID AGONISTS; FEVER; FLUMAZENIL; GABA ANTAGONISTS; GABA MODULATORS; MALE; MICE; PHOSPHINIC ACIDS; PIPERAZINES; PROPANOLAMINES; PYRIDINES; RECEPTORS, AMPA; RITANSERIN; SEROTONIN ANTAGONISTS; SOCIAL ISOLATION; STRESS, PSYCHOLOGICAL; SULFONAMIDES;

EID: 80054098333     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2011.07.042     Document Type: Conference Paper

References (62)

1. Y. Ago, Y. Koyama, A. Baba, and T. Matsuda Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex Neuropharmacology 45 8 2003 1050 1056 (Pubitemid 37412250)
2. F. Artigas, L. Romero, C. de Montigny, and P. Blier Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonist Trends Neurosci. 19 9 1996 378 383 (Pubitemid 26270513)
3. N.M. Barnes, and T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 8 1999 1083 1152 (Pubitemid 29292403)
4. F. Borsini, A. Lecci, G. Volterra, and A. Meli A model to measure anticipatory anxiety in mice? Psychopharmacology 98 1989 207 211 (Pubitemid 19137733)
5. J.A. Bouwknecht, T.H. Hijzen, J. van der Gugten, R.A.A. Maes, and B. Olivier Stress-induced hyperthermia in mice: effects of flesinoxan on heart rate and body temperature Eur. J. Pharmacol. 400 2000 59 66 (Pubitemid 30412109)
6. A.J. Bouwknecht, B. Olivier, and E.R. Paylor The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse Neurosci. Biobehav. Rev. 31 2007 41 59 (Pubitemid 44880072)
7. J.P. Conn, and C.K. Jones Promise of mGlu2/3 activators in psychiatry Neuropsychopharmacology 34 1 2009 248 249
8. P.J. Conn, and J.P. Pin Pharmacology and functions of metabotropic glutamate receptors Ann. Rev. Pharmacol. Toxicol. 37 1997 205 237 (Pubitemid 27238875)
9. B receptor-positive modulator GS39783 (N, N′-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6- diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines J. Pharmacol. Exp. Ther. 310 2004 952 963 (Pubitemid 39108915)
10. E. Chojnacka-Wójcik, A. Kłodzinska, and A. Pilc Glutamate receptor ligands as anxiolytics Curr. Opin. Invest. Drugs 2 2001 1112 1119 (Pubitemid 32782621)
11. G. De Sarro, E. Palma, N. Costa, R. Marra, S. Gratteri, A. De Sarro, and D. Rotiroti Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice Neuropharmacology 39 11 2000 2147 2161 (Pubitemid 30645638)
12. E. Dunayevich, J. Erickson, L. Levine, R. Landbloom, D.D. Schoepp, and G.D. Tollefson Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder Neuropsychopharmacology 33 2008 1603 1610 (Pubitemid 351684700)
13. M.J. Fell, J.M. Witkin, J.F. Falcone, J.S. Katner, K.W. Perry, J. Hart, L. Rorick-Kehn, C.D. Overshiner, K. Rasmussen, S.F. Chaney, M.J. Benvenga, X. Li, D.L. Marlow, L.K. Thompson, S.K. Luecke, K.A. Wafford, W.F. Seidel, D.M. Edgar, A.T. Quets, C.C. Felder, X. Wang, B.A. Heinz, A. Nikolayev, M.S. Kuo, D. Mayhugh, A. Khilevich, D. Zhang, P.J. Ebert, J.A. Eckstein, B.L. Ackermann, S.P. Swanson, J.T. Catlow, R.A. Dean, K. Jackson, S. Tauscher-Wisniewski, G.J. Marek, J.M. Schkeryantz, and K.A. Svensson N-(4-((2-(trifluoromethyl)-3-hydroxy- 4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes J. Pharmacol. Exp. Ther. 336 2011 165 177
14. A. Fletcher, E.A. Forster, D.J. Bill, G. Brown, I.A. Cliffe, J.E. Hartley, D.E. Jones, A. McLeachan, K.J. Stanhope, D.J. Critchley, K.J. Childs, V.C. Middlefell, L. Lanfumey, R. Corradetti, A.M. Lapore, H. Gozlan, M. Hamon, and C.T. Douris Electrophysiological, biochemical, neurohormonal and behavioral studies with WAY100635, a potent, selective and silent 5-HT1A receptor antagonist Behav. Brain Res. 73 1996 337 353
15. R. Galici, N.G. Echemendia, A.L. Rodriguez, and P.J. Conn A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity J. Pharmacol. Exp. Ther. 315 2005 1181 1187 (Pubitemid 41635406)
16. J. González-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, J.F. López-Giménez, M. Zhou, Y. Okawa, L.F. Callado, G. Milligan, J.A. Gingrich, M. Filizola, J.J. Meana, and S.C. Sealfon Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97 (Pubitemid 351355090)
17. G. Gu, D.S. Lorrain, H. Wei, R.L. Cole, X. Zhang, L.P. Daggett, H.J. Schaffhauser, L.J. Bristow, and S.M. Lechner Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: implication in emotional responses and central disinhibition Brain Res. 1197 2008 47 62
18. G.A. Gudelsky, J.I. Koenig, and H.Y. Meltzer Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat Neuropharmacology 25 1986 1307 1313
19. W.E. Haefely Central actions of benzodiazepines: general introduction Br. J. Psychiatry 133 1978 231 238 (Pubitemid 8392307)
20. D.R. Helton, J.P. Tizzano, J.A. Monn, D.D. Schoepp, and M.J. Kallman Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors J. Pharmacol. Exp. Ther. 284 1998 651 660 (Pubitemid 28086655)
21. J.A. van der Heyden, T.J. Zethof, and B. Olivier Stress-induced hyperthermia in singly housed mice Physiol. Behav. 62 1997 463 470 (Pubitemid 27376279)
22. J.R. Homberg, S.F. De Boer, H.S. Raasø, J.D. Olivier, M. Verheul, E. Ronken, A.R. Cools, B.A. Ellenbroek, A.N. Schoffelmeer, L.J. Vanderschuren, T.J. De Vries, and E. Cuppen Adaptations in pre- and postsynaptic 5-HT1A receptor function and cocaine supersensitivity in serotonin transporter knockout rats Psychopharmacology (Berl.) 200 3 2008 367 380
23. D. Hoyer, D.E. Clarke, J.R. Fozard, P.R. Hartig, G.R. Martin, E.J. Mylecharane, P.R. Saxena, and P.P. Humphrey International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol. Rev. 46 1994 157 203 (Pubitemid 24185150)
24. M. Iijima, T. Shimazaki, A. Ito, and S. Chaki Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice Psychopharmacology (Berl.) 190 2 2007 233 239 (Pubitemid 46011183)
25. G. Imre The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268 CNS Drug Rev. 13 2007 444 464 (Pubitemid 350233471)
26. B receptor positive modulator CGP7930 in rodents Neuropharmacology 54 2008 854 862
27. Johnson, M.P., Barda, D., Britton, T.C., Emkey, R., Hornback, W.J., Jagdmann, G.E., McKinzie, D.L., Nisenbaum, E.S., Tizzano, J.P., Schoepp, D.D., 2005. Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). 179, 271-283.
28. M.P. Johnson, M. Baez, G.E. Jagdmann Jr., T.C. Britton, T.H. Large, D.O. Callagaro, J.P. Tizzano, J.A. Monn, and D.D. Schoepp Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl) pyrid-3-ylmethylamine J. Med. Chem. 46 2003 3189 3192 (Pubitemid 36842403)
29. A. Kłodzińska, E. Chojnacka-Wójcik, A. Pałucha, P. Brański, P. Popik, and A. Pilc Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models Neuropharmacology 38 1999 1831 1839 (Pubitemid 29509721)
30. A. Klodzinska, E. Tatarczyńska, E. Chojnacka-Wójcik, G. Nowak, N.D. Cosford, and A. Pilc Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling Neuropharmacology 47 3 2004 342 350 (Pubitemid 38953225)
31. A. Lecci, F. Borsini, A. Mancinelli, V. D'Aranno, M.A. Stasi, G. Volterra, and A. Meli Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice J. Neural Trans. [Gen. Sec.] 82 1990 219 230 (Pubitemid 20319406)
32. A. Lecci, F. Borsini, G. Volterra, and A. Meli Pharmacological validation of a novel animal model of anticipatory anxiety in mice Psychopharmacology 101 1990 255 261 (Pubitemid 20140228)
33. A.M. Linden, and D.D. Schoepp Metabotropic glutamate receptor targets for neuropsychiatric disorders Drug Discovery Today Therapeut. Strat. 3 4 2006 507 517 (Pubitemid 46076174)
34. R. Lujan, J.D. Roberts, R. Shigemoto, H. Ohishi, and P. Somogyi Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites J. Chem. Neuroanat. 13 1997 219 241 (Pubitemid 27499502)
35. M.J. Millan The neurobiology and control of anxious states Prog. Neurobiol. 70 2 2003 83 244 (Pubitemid 37309295)
36. J.A. Monn, M.J. Valli, S.M. Massey, M.M. Hansen, T.J. Kress, J.P. Wepsiec, A.R. Harkness, J.L. Grutsch Jr., R.A. Wright, B.G. Johnson, S.L. Andis, A. Kingston, R. Tomlinson, R. Lewis, K.R. Griffey, J.P. Tizzano, and D.D. Schoepp Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors J. Med. Chem. 42 1999 1027 1040 (Pubitemid 29153432)
37. J.A. Monn, M.J. Valli, S.M. Massey, R.A. Wright, C.R. Salhoff, B.G. Johnson, T. Howe, C.A. Alt, G.A. Rhodes, R.L. Robey, K.R. Griffey, J.P. Tizzano, M.J. Kallman, D.R. Helton, and D.D. Schoepp Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6- dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties J. Med. Chem. 40 1997 528 537 (Pubitemid 27080033)
38. J.D. Olivier, A.R. Cools, B. Olivier, J.R. Homberg, E. Cuppen, and B.A. Ellenbroek Stress-induced hyperthermia and basal body temperature are mediated by different 5-HT(1A) receptor populations: a study in SERT knockout rats Eur. J. Pharmacol. 590 1-3 2008 190 197
39. B. Olivier, T.J. Zethof, E. Ronken, and J.A. van der Heyden Anxiolytic effects of flesinoxan in the stress-induced hyperthermiaparadigm in singly-housed mice are 5-HT1A mediated Eur. J. Pharmacol. 342 1998 177 182 (Pubitemid 28149966)
40. A. Palucha, and A. Pilc Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs Pharmacol. Ther. 115 2007 116 147 (Pubitemid 46992810)
41. A. Pałucha-Poniewiera, P. Brański, T. Lenda, and A. Pilc The Antidepressant-like action of mGlu7 receptor agonist, N, N′-Bis (Diphenylmethyl)-1,2-ethanediamine (AMN082), is serotonin-dependent J. Pharmacol. Exp. Ther. 334 2010 1066 1074
42. A. Pałucha-Poniewiera, J.M. Wierońska, P. Brański, K. Stachowicz, S. Chaki, and A. Pilc On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039 Psychopharmacology (Berl.) 212 4 2010 523 535
43. R.S. Petralia, Y.X. Wang, A.S. Niedzielski, and R.J. Wenthold The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 71 1996 949 976 (Pubitemid 26090013)
44. J.P. Pin, and R. Duvoisin The metabotropic glutamate receptors: structure and functions Neuropharmacology 34 1995 1 26
45. M. Sakaue, P. Somboonthum, B. Nishihara, Y. Koyama, H. Hashimoto, A. Baba, and T. Matsuda Postsynaptic 5-hydroxytryptamine (1A) receptor activation increases in vivo dopamine release in rat prefrontal cortex Br. J. Pharmacol. 129 2000 1028 1034 (Pubitemid 30142918)
46. A. Satow, S. Maehara, S. Ise, H. Hikichi, M. Fukushima, G. Suzuki, T. Kimura, T. Tanak, S. Ito, H. Kawamoto, and H. Ohta Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3- yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine- 1(2H)-carboxamide] J. Pharmacol. Exp. Ther. 326 2008 577 586
47. D.D. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J. Pharmacol. Exp. Ther. 299 2001 12 20 (Pubitemid 32905113)
48. D.D. Schoepp, B.G. Johnson, R.A. Wright, C.R. Salhoff, N.G. Mayne, S. Wu, S.L. Cockerman, J.P. Burnett, R. Belegaje, D. Bleakman, and J.A. Monn LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors Neuropharmacology 36 1997 1 11 (Pubitemid 27115837)
49. B receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent J. Pharmacol. Exp. Ther. 312 1 2005 290 296 (Pubitemid 40096480)
50. W.P. Spooren, P. Schoeffter, F. Gasparini, R. Kuhn, and C. Gentsch Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608) Eur. J. Pharmacol. 435 2002 161 170 (Pubitemid 34131696)
51. K. Stachowicz, E. Chojnacka-Wójcik, K. Kłak, and A. Pilc Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent Neuropharmacology 52 2007 306 312 (Pubitemid 46123350)
52. K. Stachowicz, A. Kłodzińska, A. Palucha-Poniewiera, S. Schann, P. Neuville, and A. Pilc The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems Neuropharmacology 57 2009 227 234
53. C.J. Swanson, M. Bures, M.P. Johnson, A.M. Linden, J.A. Monn, and D.D. Schoepp Metabotropic glutamate receptors as novel targets for anxiety and stress disorders Nat. Rev. Discov. 4 2005 131 144 (Pubitemid 40277494)
54. J.P. Tizzano, K.I. Griffey, and D.D. Schoepp The anxiolytic action of mGlu2/3 receptor agonist, LY354740, in the fear-potentiated startle model in rats is mechanistically distinct from diazepam Pharmacol. Biochem. Behav. 73 2002 367 374 (Pubitemid 34773438)
55. J.M. Uslaner, S.M. Smith, S.L. Huszar, R. Pachmerhiwala, R.M. Hinchliffe, J.D. Vardigan, and P.H. Hutson Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants Psychopharmacology (Berl.) 206 4 2009 641 651
56. C.H. Vinkers, R. van Oorschot, S.M. Korte, B. Olivier, and L. Groenink 5-HT1A receptor blockade reverses GABA(A) receptor alpha3 subunit-mediated anxiolytic effects on stress-induced hyperthermia Psychopharmacology (Berl.) 211 2 2010 123 130
57. K. Wedzony, A. Chocyk, and M. Maćkowiak A search for colocalization of serotonin 5-HT2A and 5-HT1A receptors in the rat medial prefrontal and entorhinal cortices-immunohistochemical studies J. Physiol. Pharmacol. 59 2 2008 229 238 (Pubitemid 351955749)
58. J.M. Wieronska, G. Nowak, and A. Pilc Metabotropic approaches to anxiety P. Skolnick, Milstones in Drug Therapy: Glutamate-based Therapies for Psychiatric Disorders 2010 Springer Basel AG 157 173
59. J.M. Wierońska, K. Stachowicz, A. Pałucha-Poniewiera, F. Acher, P. Brański, and A. Pilc Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems Neuropharmacology 59 2010 627 634
60. J.M. Wierońska, and A. Pilc Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs Neurochem. Int. 55 1-3 2009 85 97
61. A signaling Neuropsychopharmacology 29 2004 514 521 (Pubitemid 38365927)
62. A. Yasuhara, and S. Chaki Metabotropic glutamate receptors:potential drug targets for psychiatric disorders Open Med. Chem. J. 4 2010 20 36